Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron

JM Powers, M Shamoun, TL McCavit, L Adix… - The Journal of …, 2017 - Elsevier
Objective To assess the benefits and risks of intravenous (IV) ferric carboxymaltose (FCM)
in children with iron deficiency anemia (IDA). Study design In a retrospective cohort study of …

[HTML][HTML] Characterizing bulk rigidity of rigid red blood cell populations in sickle-cell disease patients

M Gutierrez, M Shamoun, KG Seu, T Tanski… - Scientific Reports, 2021 - nature.com
In this work, we utilized a parameterization model of ektacytometry to quantify the bulk rigidity
of the rigid red blood cell (RBC) population in sickle cell disease (SCD) patients. Current …

Oxidation of the natural amino acids by a ferryl complex: kinetic and mechanistic studies with peptide model compounds

…, AA Campanali, AR Ekkati, M Shamoun… - Inorganic …, 2009 - ACS Publications
Kinetic and mechanistic studies detailing the oxidation of substrates derived from the 20
natural amino acids by the ferryl complex [Fe IV (O)(N4Py)] 2+ are described. Substrates of the …

Childhood B-cell acute lymphoblastic leukemia following SARS CoV-2 infection: a potential second “hit” in leukemogenesis

Y Persaud, M Shamoun, M Chitlur… - Journal of Pediatric …, 2021 - journals.lww.com
The Coronavirus Disease 2019 (COVID-19) pandemic has become the worst pandemic in
modern history. The lack of prior immunity to the virus has resulted in a high mortality rate, …

[HTML][HTML] Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase …

…, P Rai, J Min, X Hu, D Chirovsky, M Shamoun… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Background Front-line therapy with an EGFR tyrosine kinase inhibitor (TKI) is the standard
of care for treating patients with advanced nonsquamous NSCLC with the common …

[HTML][HTML] Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron Therapy

JM Powers, MP Shamoun, TL McCavit, L Adix… - Blood, 2015 - Elsevier
Background The standard first line therapy for iron deficiency anemia (IDA) is oral iron. Yet,
many patients fail to respond to oral iron due to poor adherence and/or adverse effects. …

[HTML][HTML] The effect of azithromycin on relapse in patients with moderate-severe chronic graft versus host disease (CGVHD)

M Shamoun, T Braun, JM Magenau, SW Choi… - Biology of Blood and …, 2019 - Elsevier
BACKGROUND A recent US Food and Drug Administration (FDA) safety communication (Aug
2018) warned prescribers of the risk of relapse in patients receiving azithromycin as …

CD14/16 monocyte profiling in juvenile myelomonocytic leukemia

M Gadgeel, S Bagla, S Buck, M Shamoun… - Pediatric Blood & …, 2020 - Wiley Online Library
Monocyte subset analysis by flow cytometry has been shown to be a useful diagnostic tool in
chronic myelomonocytic leukemia in adults. An increase in the classical monocyte fraction (…

Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of …

…, T Kurata, Y Cheng, E Jensen, M Shamoun… - Journal of Thoracic …, 2024 - Elsevier
Background We report long-term outcomes from a pooled analysis of patients with
previously untreated metastatic NSCLC with programmed cell death ligand 1 (PD-L1) tumor …

Thalassemia

M Shamoun, M Callaghan - Benign Hematologic Disorders in Children: A …, 2020 - Springer
Thalassemia is a group of hereditary disorders affecting hemoglobin production leading to
increased hemolysis and impaired production of red blood cells. Defects can arise in both the …